Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

3D BIOTEK LLC

UEI: FJ3JZ8RBUQ51

3D BIOTEK LLC is a federal contractor, registered under UEI FJ3JZ8RBUQ51. It has been awarded $602,642 across 5 federal contracts. Primary work spans Unknown NAICS and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services, National Science Foundation, and Department Of Commerce.

Contact Information

Registration and classification details

Registration

UEI Code

FJ3JZ8RBUQ51

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$337.9K56.1%

National Science Foundation$225.0K37.3%

Department Of Commerce$24.9K4.1%

Department Of Veterans Affairs$14.9K2.5%

Awards by NAICS

- Unknown NAICS$562.9K93.4%

541711 - Research and Development in Biotechnology$39.8K6.6%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in 3D BIOTEK LLC's top NAICS codes and agencies

Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

Domestic Shipping and Delivery CoordinationThe contract pertains to the coordination of domestic shipping and delivery of sensitive electronic test equipment to the National Institute of Standards and Technology in Boulder, Colorado, with a strict requirement for ESD-compliant packaging to safeguard equipment integrity during transit. All shipments must be fully compatible with standard handling procedures of major carriers such as UPS and FedEx, ensuring secure, reliable, and traceable delivery without risk of damage from static discharge or improper handling. The work is classified under NAICS code 484220, indicating it involves freight transportation by truck, and is structured as a subcontract under the Department of Commerce. Responses are due by August 6, 2026, at 5:00 p.m. Eastern Time, following a posting date of July 27, 2026, with performance centered exclusively at the Boulder location with the ZIP code 80305. There is no set-aside designation specified, and the contract does not identify a point of contact or office address beyond the place of performance. The solicitation is accessible via the SAM.gov portal and requires vendors to demonstrate expertise in shipping high-value, electronics-based test instruments under stringent environmental and handling protocols.

Department Of Commerce

POSTED

DEADLINE

Warranty and Post-Delivery Support ServicesA one-year warranty is provided for the wirebond-pull tester covering all parts, labor, and return logistics necessary for repairs, ensuring comprehensive service support after delivery. This includes technical support and troubleshooting assistance to maintain operational integrity and minimize downtime. The contract falls under the NAICS code 811212 and is issued by the Department of Commerce with performance located in Boulder, Colorado, at the ZIP code 80305. The solicitation was posted on July 27, 2026, with responses due by August 6, 2026, and is classified as a subcontract opportunity without a specific set-aside designation. All maintenance and service obligations are to be fulfilled in alignment with the terms outlined, ensuring the equipment remains functional and supported throughout the warranty period.

Department Of Commerce

POSTED

DEADLINE

Technical Documentation and User Manual DeliveryThe contract requires the production and delivery of comprehensive technical documentation for a wirebond-pull tester, including both electronic and printed versions of full installation and user manuals. These manuals must provide detailed utility requirements, operational guidance, and clear instructions to ensure proper setup and use of the equipment. All deliverables must meet precise technical standards and be tailored to support end-user functionality across multiple formats. The solicitation is issued as a subcontract under NAICS code 541830 by the Department of Commerce, with performance required in Boulder, Colorado, at ZIP code 80305. Responses are due by August 6, 2026, and the opportunity was posted on July 27, 2026. The contract focuses exclusively on the creation and delivery of high-quality documentation, with no indication of additional services or equipment procurement. The place of performance and the nature of the deliverables suggest the work will be conducted remotely or locally by a technical documentation provider with expertise in scientific instrumentation manuals.

Department Of Commerce

POSTED

DEADLINE

Supply of Dual-Use Benchtop Wirebond-Pull Tester with A-1 Tweezer FeatureThe contract seeks the procurement and delivery of a new, non-refurbished West Bond 70PTE E-Series wirebond-pull tester equipped with an A-1 Tweezer attachment, specifically designed to integrate seamlessly with existing West Bond systems utilized in the assembly of NASA’s Athena mission hardware. The equipment must be factory fresh and fully compatible with current instrumentation to ensure consistent, reliable performance in high-precision bonding validation tasks critical to mission integrity. Delivery is required to meet stringent technical specifications and operational standards aligned with aerospace quality benchmarks. Performance of this contract is designated for Boulder, Colorado, with a response deadline of August 6, 2026, and the solicitation was posted on July 27, 2026. This action falls under the NAICS code 333318, categorizing it as a subcontract for other manufacturing machinery. Although the contracting agency is listed as the Department of Commerce, the end-user context clearly ties the equipment to NASA’s Athena mission, indicating interagency coordination for specialized hardware support. There is no set-aside designation, and the opportunity is open to qualified industrial suppliers capable of meeting the technical, delivery, and compatibility requirements without refurbishment or reconditioning.

Department Of Commerce

POSTED

DEADLINE

Notice of Intent to Sole Source Wirebond Pull Tester

Solicitation # NB687000-26-02180

The National Institute of Standards and Technology (NIST) plans to award a sole-source firm-fixed-price purchase order to K&R Next Generation Bonding Inc. for a West Bond 70PTE Wire Pull Tester, “E” Series, equipped with an A-1 Tweezer Feature, due to the manufacturer’s discontinuation and the exclusive authorization of this vendor to supply new original equipment. The instrument must meet precise technical specifications including a binocular microscope with 10x eyepieces, twin-array LED illumination, a z-tool range of at least 9/16 inch, z-encoder resolution of 0.002 inch, a test force range of at least 100 grams, force resolution of 0.1 gram or better, force accuracy within ±0.2 gram, ESD protection, and a single-lever dual-counterbalanced micromanipulator with an 8:1 motion-reduction ratio, all while providing a one-year parts warranty. This system is critical for the NIST Quantum Sensors Division’s work on NASA’s Athena X-ray astronomy mission, where precise measurement and controlled removal of wirebonds on flight hardware are required. The decision for sole sourcing is driven by the necessity to maintain compatibility with NIST’s existing fleet of six West Bond wirebonders and diebonders, which share identical optical, mechanical, and electronic components, including the same micromanipulator, stage, control electronics, and tweezer attachments. The division’s 35 current operators are already extensively trained on West Bond systems, and super-users possess proprietary repair knowledge and an established inventory of compatible spare parts. The new tester will be deployed in the commissioning flight lab and is expected to be operated by six to eight current users, eliminating the need for retraining and ensuring seamless integration into existing workflows. West Bond ceased operations at the end of 2025, and K&R Next Generation Bonding Inc. is the sole authorized distributor of new, original West Bond equipment, making it the only viable source for this specific model. The acquisition is governed under FAR Subpart 6.302-1, with a response deadline of August 6, 2026, and an anticipated award on or before August 28, 2026.

Department Of Commerce

POSTED

DEADLINE

Induced Pluripotent Stem Cell (iPSC) Reprogramming ServicesThe contract entails the reprogramming of human articular chondrocytes and bone marrow cells into induced pluripotent stem cells using Sendai virus technology, with full support for culture expansion and cryopreservation of the resulting iPSCs. This subcontract is part of a research initiative led by the Department of Veterans Affairs through Rpo East, focused on advancing regenerative medicine techniques through advanced cellular reprogramming methods. The work requires precise adherence to protocols ensuring high efficiency, safety, and scalability of iPSC generation while maintaining cell viability and pluripotency throughout the process. The solicitation is open for responses until August 6, 2026, and falls under NAICS code 541711, indicating it is for research and development in the biological sciences. The agreement is structured as a subcontract, suggesting it will be awarded to a specialized contractor with expertise in stem cell biology and virology-based reprogramming. Performance is expected to meet rigorous quality standards for cellular products intended for potential therapeutic or diagnostic applications, with an emphasis on reproducibility and documentation. All deliverables must include verified iPSC lines archived through cryopreservation, ready for downstream use in future studies or clinical translation.

Rpo East (36C24E)

POSTED

DEADLINE

Emerging Animal & Zoonotic Disease Diagnostics Research

Sci Technology Acq Division

POSTED

DEADLINE

OHS Region 11 Training and Technical Assistance Network

Solicitation # 7571MN26C00013

The Department of the Interior’s existing contract with ICF Incorporated, LLC, numbered 140D0425C0027, has been administratively transferred to the Department of Health and Human Services under a new task order, 7571MN26C00013, effective July 1, 2026. This transfer is purely administrative and does not alter the original contract’s scope of work, deliverables, ultimate value, or period of performance. The work continues under the same terms and conditions, now managed by HHS to support the OHS Region 11 Training and Technical Assistance Network, with performance based in Reston, Virginia, and administrative oversight from Washington, DC. The contract, classified under NAICS code 541611, remains unrestricted with no set-aside requirements and is fully maintained under the original contractor’s responsibility. Point of contact for inquiries includes Carla Carter and Hamed Hassanzadeh Makou at HHS.

Department Of Health And Human Services

POSTED

DEADLINE

Phase 2/3 Clinical Trial ExecutionThe contract pertains to the execution of Phase 2/3 clinical trials focused on acute pain management, requiring full management of trial operations including site selection, patient recruitment, data collection, and safety monitoring in strict compliance with FDA regulations. The work will be performed in Frederick, Maryland, with a post date of June 29, 2026, and a response deadline of July 30, 2026, at 5:00 PM. This is a subcontract under the Defense Health Agency, part of the Department of Defense, and falls under NAICS code 541711 for research and development in the physical, engineering, and life sciences. All activities must adhere to regulatory standards to ensure trial integrity, patient safety, and data reliability, with performance centered in Frederick, MD.

Defense Health Agency

POSTED

about 1 month ago

DEADLINE

in about 6 hours

Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Clinical Trial Design and Biostatistical SupportThe contract seeks specialized expertise to support clinical trial design and biostatistical analysis for orthopaedic trauma research funded by the Department of Defense, specifically under the U.S. Army Medical Research and Acquisition Activity. The work involves developing robust clinical trial methodologies, crafting statistical analysis plans, performing power analyses to ensure adequate sample sizes, and establishing data monitoring frameworks to ensure trial integrity and compliance with regulatory standards. Support must be tailored to the unique challenges of military-relevant trauma studies, including patient populations, deployment-related injuries, and the operational constraints of DoD medical settings. The opportunity is structured as a subcontract with a NAICS code of 541711, indicating it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, and responses are due by November 18, 2026. Performance is expected to occur within the broader DoD infrastructure, though no specific location is designated. There is no set-aside classification specified, and the contract is open to qualified entities capable of delivering high-level biostatistical and clinical trial methodological support in a defense medical research context.

Department Of The Army -- Usamraa

POSTED

about 1 month ago

DEADLINE

Preclinical Biomedical Research on Traumatic Orthopaedic InjuriesThis contract requires the conduct of preclinical biomedical research focused on bone healing, tissue regeneration, and orthopaedic trauma models using animal systems, with the goal of advancing medical solutions aligned with military needs. The work involves designing controlled experiments, collecting longitudinal data on injury response and recovery, and performing rigorous statistical and biological analysis to evaluate therapeutic interventions. All research must be tailored to simulate combat-related orthopaedic injuries and produce actionable insights applicable to field medical care and soldier recovery protocols. The effort is structured as a subcontract under the Department of the Army through USAMRAA, with a solicitation posted on June 17, 2026, and a response deadline of November 18, 2026. The project falls under NAICS code 541711 for research and development in the physical, engineering, and life sciences. Performance location and point of contact details are not specified, but the research must be executed in facilities capable of supporting high-standard animal modeling and biomechanical analysis. The ultimate objective is to generate validated preclinical data to inform the development of next-generation treatments for traumatic injuries sustained in military operations.

Department Of The Army -- Usamraa

POSTED

about 1 month ago

DEADLINE

Nanobody-Drug Conjugate Systems DevelopmentThe contract pertains to the licensing of the NanoFET platform to develop targeted nanobody-drug conjugates for the precision delivery of therapeutics using a modular scaffold designed to enhance specificity and efficiency in therapeutic distribution. This subcontract, issued by the Department of Energy through its contractor Triad, enables the recipient to leverage the proprietary NanoFET technology for advancing next-generation drug delivery systems with a focus on oncology and other targeted disease treatments. The project is centered in Los Alamos, New Mexico, with a response deadline of December 18, 2026, and falls under the NAICS code 541711 for research and development in biotechnology. The modular scaffold allows for customizable conjugation of nanobodies with therapeutic payloads, facilitating high-affinity targeting of disease markers while minimizing off-target effects. The agreement emphasizes technological innovation and the translation of advanced nanoscale platforms into clinically viable delivery systems.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE